Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Light harvesting with multiwall carbon nanotube/silicon heterojunctions.
Castrucci P, Scilletta C, Del Gobbo S, Scarselli M, Camilli L, Simeoni M, Delley B, Continenza A, De Crescenzi M. Castrucci P, et al. Among authors: simeoni m. Nanotechnology. 2011 Mar 18;22(11):115701. doi: 10.1088/0957-4484/22/11/115701. Epub 2011 Feb 4. Nanotechnology. 2011. PMID: 21297234
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review.
Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, Mani LY, Mattace-Raso F, Pepin M, Perico N, Simeoni M, Zoccali C, Tortorella G, Capuano A, Remuzzi G, Capasso G, Paolisso G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators. Barbieri M, et al. Among authors: simeoni m. Pharmacol Res. 2024 May;203:107146. doi: 10.1016/j.phrs.2024.107146. Epub 2024 Mar 16. Pharmacol Res. 2024. PMID: 38493928 Free article. Review.
Correction: Identifying behaviour change techniques in 287 randomized controlled trials of audit and feedback interventions targeting practice change among healthcare professionals.
Crawshaw J, Meyer C, Antonopoulou V, Antony J, Grimshaw JM, Ivers N, Konnyu K, Lacroix M, Presseau J, Simeoni M, Yogasingam S, Lorencatto F. Crawshaw J, et al. Among authors: simeoni m. Implement Sci. 2023 Dec 18;18(1):73. doi: 10.1186/s13012-023-01328-6. Implement Sci. 2023. PMID: 38111031 Free PMC article. No abstract available.
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.
Hafez G, Malyszko J, Golenia A, Klimkowicz-Mrowiec A, Ferreira AC, Arıcı M, Bruchfeld A, Nitsch D, Massy ZA, Pépin M, Capasso G, Mani LY, Liabeuf S; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Hafez G, et al. Clin Kidney J. 2023 Sep 18;16(12):2378-2392. doi: 10.1093/ckj/sfad239. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38046029 Free PMC article. Review.
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor.
Liabeuf S, Pešić V, Spasovski G, Maciulaitis R, Bobot M, Farinha A, Wagner CA, Unwin RJ, Capasso G, Bumblyte IA, Hafez G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Liabeuf S, et al. Clin Kidney J. 2023 Sep 18;16(12):2365-2377. doi: 10.1093/ckj/sfad241. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38045996 Free PMC article. Review.
228 results